Back

All ‘ablate and pace’ patients with heart failure and atrial fibrillation should be offered physiological pacing regardless of left ventricular function: con

27 August 2023 (09:30 - 09:45)
Organised by: Logo
Congress Presentation Part of: Great Debate: how to manage patients with heart failure and atrial fibrillation Treatment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
First-line atrial fibrillation ablation should be offered to all patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF): pro
Professor N. Marrouche (New Orleans, US)
Slides Video
Presentation thumbnail
First-line atrial fibrillation ablation should be offered to all patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF): con
Professor I. Van Gelder (Groningen, NL)
Slides Video
Presentation thumbnail
First-line atrial fibrillation ablation should be offered to all patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF) - discussion
Video
Presentation thumbnail
All ‘ablate and pace’ patients with heart failure and atrial fibrillation should be offered physiological pacing regardless of left ventricular function: pro
Professor M. Jastrzebski (Krakow, PL)
Slides Video
Presentation thumbnail
All ‘ablate and pace’ patients with heart failure and atrial fibrillation should be offered physiological pacing regardless of left ventricular function - discussion
Video

Access the full session

Session thumbnail
Great Debate: how to manage patients with heart failure and atrial fibrillation
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 09:30 CET
You may be interested in
thumbnail
Congress Presentation
First-line atrial fibrillation ablation should be offered to all patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF): pro

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources